Table 2. Percentages of mutant mtDNA as determined using pyrosequencing.
Subject | Sample | m.5556G>A | m.10450A>G |
---|---|---|---|
Patient | Fibroblasts | 92 | 92 |
Skeletal muscle | 93 | 93 | |
Cybrid clone 1 | 90 | 91 | |
Cybrid clone 2 | 93 | 90 | |
Cybrid clone 3 | 96 | 88 | |
Mother | Blood | 0 | 0 |
Fibroblasts | ND | 18 |
Abbreviation: ND, not determined.